Skip to main content
Clinical Trials/JPRN-UMIN000051363
JPRN-UMIN000051363
Completed
未知

Evaluation of the efficacy of test food on LDL-cholesterol - Evaluation of the efficacy of test food on LDL-cholesterol

KAGOME CO., LTD.0 sites100 target enrollmentJune 19, 2023
ConditionsHealthy adults

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy adults
Sponsor
KAGOME CO., LTD.
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 19, 2023
End Date
December 7, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects with dyslipidemia or familial hypercholesterolemia. 2\. Subjects who have a disease under treatment or have a history of serious disease (dyslipidemia, diabetes, liver disease, renal disease, cardiac disease, psychiatric disease, etc.) that required medication treatment. 3\. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc . 4\. Subjects those who use health foods that may affect lifestyle\-related diseases (blood lipid, blood pressure, blood glucose, uric acid levels). 5\. Subjects who have had allergic reactions to drugs or foods especially test food. 6\. Subjects who regularly take foods containing a large amount of plant\-derived component. 7\. Subjects who smoke excessive amounts of cigarettes on a daily basis (21 cigarettes/day or more). 8\. Subjects who drink excessive amounts of alcohol on a daily basis (more than 20 g/day of pure alcohol equivalent three times or more per week). 9\. Subjects who have an exercise habit (3 times a week or more) . 10\. Subjects who are judged to be unsuitable for the study based on their responses to the screening questionnaire. 11\. Subjects whose physical measurements, physical examination values, and clinical laboratory values on the pre\-test are significantly out of the reference range. 12\. Subjects who are participating in other clinical studies at the time this study is initiated. 13\. Women who expected to be pregnant or lactating during this study. 14\. Subjects who have irregular lifestyle such as shift workers, late night workers, etc. 15\. Subjects who are judged unsuitable for this study by the principal investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials